UnknownNot Applicable

Robotic-assisted Esophagectomy vs. Video-Assisted Thoracoscopic Esophagectomy(REVATE) Trial

Taiwan212 participantsStarted 2018-10-22

Plain-language summary

The investigators will assess the adequacy of nodal dissection along the recurrent laryngeal nerve performed with robot-assisted versus video-assisted thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma through a prospective multicentre randomized study design.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age between 18\~80
✓. Histologically proven primary intrathoracic esophageal squamous cell carcinoma and will undergo McKeown MIE and bilateral RLN LND.
✓. Patients should have a performance status 0, 1 or 2 according to the European Clinical Oncology Group.
✓. Surgical resectable(cT1\~4a, N0\~3, M0)
✓. Written informed consent

Exclusion criteria

✕. Previous major thoracic surgery rendering minimal invasive approach unfeasible
✕. prognosis determining malignancy other than esophageal cancer, inability to undergo curative resection and/or follow-up
✕. inability to provide oral or written informed consent.
✕. pre-existed vocal cord dysfunction will also be excluded.

What they're measuring

Rate of unsuccessful LND along the left RLN

Timeframe: Till 6 months postoperatively

Trial details

NCT IDNCT03713749

SponsorChang Gung Memorial Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-04-22

View on ClinicalTrials.gov More Esophageal Squamous Cell Carcinoma trials